Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Ixazomib Citrate, Lenalidomide, Dexamethasone, and Zoledronic Acid or Zoledronic Acid Alone After Radiation Therapy in Treating Patients With Solitary Plasmacytoma of Bone

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02516423
Recruitment Status : Active, not recruiting
First Posted : August 5, 2015
Last Update Posted : August 17, 2021
National Cancer Institute (NCI)
Millennium Pharmaceuticals, Inc.
Biologics, Inc.
Information provided by (Responsible Party):
Alliance for Clinical Trials in Oncology

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : September 2024
Study Completion Date : No date given